Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
MRI human brain scans

Two New Genes Linked to Alzheimer's Disease

Researchers made the discovery by exploring which genes were turned on and off in the hippocampus of patients

Published:Feb 26, 2021
|Updated:Feb 27, 2021
|2 min read

A research team led by Chunshui Yu and Mulin Jun Li of Tianjin Medical University has discovered two new genes potentially involved in Alzheimer's disease. They identified them by exploring which genes were turned on and off in the hippocampus of people with the disease. The team's new findings are published February 25, 2021, in PLOS Genetics.

Alzheimer's disease is a neurodegenerative disorder that involves worsening dementia and the formation of protein plaques and tangles in the brain. The hippocampus, part of the brain involved in memory, is one of the first regions to sustain damage. To better understand which genes contribute to the progression of this heritable disease, the researchers identified genes expressed at higher or lower levels in the hippocampus of 111 people with Alzheimer's disease compared to healthy brains.

They identified 24 Alzheimer's-related genes that appear to have an effect through the hippocampus, using previous genomic and hippocampus gene expression data. Many genes were already known to contribute to the disease, such as APOE, but two were unknown, PTPN9 and PCDHA4. Additionally, several are involved in biological process related to Alzheimer's disease, such as plaque formation and cell death.

Related Article: COVID-19 Likely to Have Long-Term Impact on the Brain

The research team further validated their findings by comparing gene expression for the two dozen genes to images of the individuals' brains. In Alzheimer's disease, damage and loss of neurons causes the hippocampus to shrink, which can be measured through medical imaging. The researchers established that expression of two of the genes is related to the size of the hippocampus and a diagnosis of Alzheimer's disease.

A schematic overview of the study design. AD = Alzheimer's disease; ADNI = Alzheimer's disease Neuroimaging Initiative; ADSP = Alzheimer's disease Sequencing Project; cis-GReX = cis-genetically regulated expression; FOCUS = Fine-mapping of causal gene sets; GWAS = Genome-wide association study; IGAP = International Genomics of Alzheimer's Project; PGC-ALZ = Alzheimer's disease working group of the Psychiatric Genomics Consortium; TWAS = Transcriptome-wide association study; UKBB = UK Biobank.
Liu N, et al., 2021, PLOS Genetics 

Overall, the new findings improve our understanding of the genetic and cellular mechanisms that cause Alzheimer's disease. The next step will be to investigate the roles of the two novel genes and how they contribute to this devastating disease.

The authors add, "The study identifies two novel genes associated with Alzheimer's disease in the context of hippocampal tissue and reveals candidate hippocampus-mediated neurobiological pathways from gene expression to Alzheimer's disease."

- This press release was provided by PLOS